|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/10/21 Rubius Therapeutics, Inc. S-8 5/10/21 3:110K Toppan Merrill Bridge/FA |
Document/Exhibit Description Pages Size
1: S-8 Registration Statement - Securities for an HTML 52K
Employee Benefit Plan
2: EX-5.1 Opinion of Counsel re: Legality HTML 9K
3: EX-23.1 Consent of Expert or Counsel HTML 6K
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Rubius Therapeutics, Inc. of our report dated February 23, 2021 relating to the financial statements, which appears in Rubius Therapeutics, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
| This ‘S-8’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / Effective on: | 5/10/21 | 10-Q, 8-K | ||
| 2/23/21 | 10-K, 8-K | |||
| 12/31/20 | 10-K | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/23/18 Rubius Therapeutics, Inc. 8-K:5,8,9 7/17/18 3:223K Toppan Merrill/FA 7/18/18 Rubius Therapeutics, Inc. S-8 7/18/18 3:157K Toppan Merrill/FA 7/09/18 Rubius Therapeutics, Inc. S-1/A 10:5.6M Toppan Merrill-FA 7/02/18 Rubius Therapeutics, Inc. S-1/A 7:1M Toppan Merrill-FA 6/22/18 Rubius Therapeutics, Inc. S-1 18:11M Toppan Merrill-FA |